A detailed history of Operose Advisors LLC transactions in Danaher Corp stock. As of the latest transaction made, Operose Advisors LLC holds 876 shares of DHR stock, worth $206,595. This represents 0.08% of its overall portfolio holdings.

Number of Shares
876
Previous 896 2.23%
Holding current value
$206,595
Previous $223,000 8.97%
% of portfolio
0.08%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$239.25 - $280.76 $4,785 - $5,615
-20 Reduced 2.23%
876 $243,000
Q4 2023

Feb 12, 2024

SELL
$185.1 - $233.13 $65,895 - $82,994
-356 Reduced 28.43%
896 $207,000
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $104,419 - $118,984
448 Added 55.72%
1,252 $310,000
Q4 2022

Feb 13, 2023

SELL
$241.42 - $282.29 $37,661 - $44,037
-156 Reduced 16.25%
804 $213,000
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $93,882 - $572,812
-380 Reduced 28.36%
960 $248,000
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $391,387 - $440,873
1,340 New
1,340 $441,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $172B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Operose Advisors LLC Portfolio

Follow Operose Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Operose Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Operose Advisors LLC with notifications on news.